Release Date: 24/09/13 11:25 Summary: App3Y DRP issue final dividend AD Price Sensitive: No Download Document 34.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%